Related Experiment Video
Updated: Sep 27, 2026
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
The diagnosis of primary progressive multiple sclerosis
1Department of Neurology, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA.
Abstract:
Primary progressive multiple sclerosis (PPMS) is a rather unique form of the more common relapsing inflammatory demyelinative disease. The absence of attacks that typify relapsing forms of MS imposes special challenges for diagnosis, but also provides an opportunity to study the pathogenesis of the more progressive aspects of the disease process in isolation of confounding transient clinical events. In this review, recent advances in diagnostic approaches are considered in relationship to baseline data from a large multinational study designed to better characterize and treat this clinical phenotype. PPMS subjects with cerebral spinal fluid (CSF) findings consistent with intrathecal immunoglobulin production may have a more tissue destructive disease process than those whose CSF lacks evidence of a B-cell immunopathogenic disease component.
Insights
Primary progressive multiple sclerosis (PPMS) presents unique diagnostic challenges. Intrathecal immunoglobulin production in cerebrospinal fluid may indicate a more destructive disease process in PPMS patients.
Area of Science:
- Neuroimmunology
- Neurology
- Demyelinating Diseases
Background:
- Primary progressive multiple sclerosis (PPMS) is a distinct subtype of multiple sclerosis characterized by gradual neurological decline without distinct relapses.
- Its unique disease course presents diagnostic challenges and offers an opportunity to study progressive neurodegeneration in isolation.
Purpose of the Study:
- To review recent advancements in diagnostic strategies for PPMS.
- To analyze baseline data from a multinational study to better characterize the PPMS phenotype.
- To explore the relationship between cerebrospinal fluid (CSF) findings and disease progression in PPMS.
Main Methods:
- Review of recent literature on PPMS diagnostics.
- Analysis of baseline data from a large multinational study involving PPMS patients.
- Correlation of CSF analysis, specifically intrathecal immunoglobulin production, with disease characteristics.
Main Results:
- Recent diagnostic advances are considered in the context of a large multinational study on PPMS.
- PPMS patients with evidence of intrathecal immunoglobulin production in CSF may exhibit a more tissue-destructive disease course.
- The absence of relapses in PPMS allows for isolated study of progressive disease mechanisms.
Conclusions:
- Diagnostic approaches for PPMS are evolving.
- Cerebrospinal fluid analysis, particularly for B-cell immunopathogenic components, may stratify PPMS patients by disease severity.
- Understanding these distinctions is crucial for targeted treatment strategies in PPMS.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:15Parkinson's Disease: Overview
01:22Myasthenia Gravis ll: Pathophysiology
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:24Parkinson Disease ll: Pathophysiology